Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy and Safety Study of Magnesium Iron Hydroxycarbonate for the Reduction of High Blood Phosphate in Hemodialysis Patients

This study has been completed.
Information provided by:
Ineos Healthcare Limited Identifier:
First received: April 21, 2006
Last updated: July 21, 2009
Last verified: July 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2007
  Primary Completion Date: June 2007 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: July 21, 2009